Identification of the characteristics and prognostic impact of <i>FUS::ERG</i> and <i>RUNX1::CBFA2T3</i> fusion genes in adult <scp>acute myeloid leukemia</scp> patients-Reference-Cited by-同舟云学术

Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients

Published:2024-04-23 Issue:7 Volume:99 Page:1441-1444
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Zhou Ziyue¹^ORCID,Zhuo Nanfang¹²,Zhou Yile¹²,Sun Caihong¹,Yao Yiyi¹²^ORCID,Mao Liping¹²³,Zhang Yi¹²³^ORCID,Hong Qing¹,Pan Peifeng¹,Tong Hongyan¹²³⁴^ORCID,Jin Jie¹²³⁴^ORCID,Wang Huafeng¹²³⁴^ORCID

Affiliation:

1. Department of Hematology The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou People's Republic of China

2. Zhejiang Provincial Key Lab of Hematopoietic Malignancy Zhejiang University Hangzhou People's Republic of China

3. Zhejiang Provincial Clinical Research Center for Hematological Disorders Hangzhou People's Republic of China

4. Zhejiang University Cancer Center Hangzhou People's Republic of China

Funder

Key Research and Development Program of Zhejiang Province

Fundamental Research Funds for the Central Universities

Natural Science Foundation of Zhejiang Province

National Natural Science Foundation of China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27340

Reference6 articles.

1. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group

2. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1

3. Consistent detection of TLS/FUS‐ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript;Kong XT;Blood,1997

4. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

5. The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia